‘FLARE’ of tumor marker in advanced gastric cancer treated with first-line systemic therapy

BACKGROUND: Transient tumor marker elevations caused by chemotherapy were defined as ‘Flare’ and have been demonstrated in some solid tumors. In clinical practice, we observed that some patients were accompanied by elevated tumor markers during treatment, but subsequent imaging proved that the treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangyuan, Zhai, Menglan, Yang, Jinru, Zhao, Lei, Lin, Zhenyu, Wang, Jing, Zhang, Tao, Yu, Dandan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523829/
https://www.ncbi.nlm.nih.gov/pubmed/36187367
http://dx.doi.org/10.1177/17562848221124029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523829/
https://www.ncbi.nlm.nih.gov/pubmed/36187367
http://dx.doi.org/10.1177/17562848221124029

Ejemplares similares